MedTrace Logo

Cerebral Microdialysis in Patients With Fulminant Hepatic Failure

NCT00836420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-10-27

No results posted yet for this study

Summary

Patients with fulminant hepatic failure (FHF) often develop cerebral edema, high intracranial pressure (ICP)that may result in fatal brain damage. The aim in this protocol is to determine if a rise in the brain concentration of glutamate, lactate and pyruvate are involved in development of surges of high ICP in patients with FHF. The study is observatory in nature and also record the influence of any intervention that may e instituted during the course of the critical illness.

Conditions

  • Fulminant Hepatic Failure

Interventions

PROCEDURE

no intervention

the value of the clinical use of microdialysis monitoring of the brain

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Fin Stolze Larsen · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00836420 on ClinicalTrials.gov